Company profile
IRadimed Corporation
NASDAQ: IRMD · Healthcare · Medical - Devices
#370 of 1,418 Healthcare companies by revenue61st-percentile growth
EA Score
86AFH 93DQ 87GM 71SS 69
v0.1 · 65/100 weight · provisional
↑ Altman-Z, operating margin · ↓ listing tenure, revenue growth (YoY)
Methodology →Revenue TTM
$86.3M
Rev growth YoY (TTM)
+14.8%
Net income (FY)
$22.5M
Employees
166
as of 2026-08-10
Market cap
$1.2B
as of 2026-08-10
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$83.8M$83.8M2025
Net income$22.5M$22.5M2025
Operating income$26.1M$26.1M2025
Total assets$108.8M$108.8M2025
Liabilities$14.2M$14.2M2025
Equity$94.6M$94.6M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
MRI Compatible Patient Vital Signs Monitoring Systems100%
By geography
UNITED STATES84%
International16%
The read
What is IRadimed Corporation’s revenue?
IRadimed Corporation booked $83.8M in FY2025 revenue, growing 14% year over year — faster than most Healthcare companies we track, at a 26.8% net margin.
Peers · Healthcare
4D Molecular Therapeutics, Inc.58CARS Pharmaceuticals, Inc.41DNurix Therapeutics, Inc.53DArcturus Therapeutics Holdings Inc.49DMeiraGTx Holdings plc48DDecibel Cannabis Company Inc.62CNeighbors
Seminole →Key facts
CEORoger E. Susi
SectorHealthcare
IndustryMedical - Devices
HeadquartersWinter Springs, FL
ExchangeNASDAQ: IRMD
Employees166
IPO date2014-07-16
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.